Publications by authors named "Agneta Jansson"

Claim this Profile
T
The regulation of hydroxysteroid 17β-dehydrogenase type 1 and 2 gene expression in breast cancer cell lines by estradiol, dihydrotestosterone, microRNAs, and genes related to breast cancer.
Erik Hilborn, Olle Stål, Andrey Alexeyenko, Agneta Jansson

Oncotarget· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estrogen and androgen-converting enzymes 17β-hydroxysteroid dehydrogenase and their involvement in cancer: with a special focus on 17β-hydroxysteroid dehydrogenase type 1, 2, and breast cancer.
Erik Hilborn, Olle Stål, Agneta Jansson

Oncotarget· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Androgen receptor expression predicts beneficial tamoxifen response in oestrogen receptor-α-negative breast cancer.
Erik Hilborn, Jelena Gacic, Tommy Fornander, Bo Nordenskjöld, Olle Stål, Agneta Jansson

Br J Cancer· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Y
YAP1 is a potential biomarker for cetuximab resistance in head and neck cancer.
Fredrik Jerhammar, Ann-Charlotte Johansson, Rebecca Ceder, Jenny Welander, Agneta Jansson

Oral Oncol· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
C-X-C ligand 10 and C-X-C receptor 3 status can predict tamoxifen treatment response in breast cancer patients.
Erik Hilborn, Tove Sivik, Tommy Fornander, Olle Stål, Bo Nordenskjöld, Agneta Jansson

Breast Cancer Res Treat· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
17β-Hydroxysteroid dehydrogenase type 14 is a predictive marker for tamoxifen response in oestrogen receptor positive breast cancer.
Tove Sivik, Cecilia Gunnarsson, Tommy Fornander, Bo Nordenskjöld, Lambert Skoog, Agneta Jansson

PLoS One· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progesterone and levonorgestrel regulate expression of 17βHSD-enzymes in progesterone receptor positive breast cancer cell line T47D.
Tove Sivik, Agneta Jansson

Biochem Biophys Res Commun· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive relevance of HOXB13 protein expression for tamoxifen benefit in breast cancer.
Piiha-Lotta Jerevall, Agneta Jansson, Tommy Fornander, Lambert Skoog, Bo Nordenskjöld

Breast Cancer Res· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A validated and rapid high-performance liquid chromatography method for the quantification of conversion of radio-labelled sex steroids.
Tove Sivik, Svante Vikingsson, Henrik Gréen, Agneta Jansson

Horm Mol Biol Clin Investig· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ratio of 17HSD1 to 17HSD2 protein expression predicts the outcome of tamoxifen treatment in postmenopausal breast cancer patients.
Agneta Jansson, Lovisa Delander, Cecilia Gunnarsson, Tommy Fornander, Lambert Skoog

Clin Cancer Res· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
17Beta-hydroxysteroid dehydrogenase enzymes and breast cancer.
Agneta Jansson

J Steroid Biochem Mol Biol· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amplification of HSD17B1 has prognostic significance in postmenopausal breast cancer.
Cecilia Gunnarsson, Piiha-Lotta Jerevall, Karl Hammar, Birgit Olsson, Bo Nordenskjöld, Agneta Jansson

Breast Cancer Res Treat· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new polymorphism in the coding region of exon four in HSD17B2 in relation to risk of sporadic and hereditary breast cancer.
Agneta Jansson, Jonas Carlsson, Anette Olsson, Petter Storm, Sara Margolin

Breast Cancer Res Treat· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
17beta-hydroxysteroid dehydrogenase 14 affects estradiol levels in breast cancer cells and is a prognostic marker in estrogen receptor-positive breast cancer.
Agneta K Jansson, Cecilia Gunnarsson, Maja Cohen, Tove Sivik, Olle Stål

Cancer Res· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of COX-2 and steroid converting enzymes in breast cancer.
Cecilia Gunnarsson, Agneta Jansson, Birgitta Holmlund, Lilianne Ferraud, Bo Nordenskjöld

Oncol Rep· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
mRNA and protein expression of PUMA in sporadic colorectal cancer.
Agneta Jansson, Gunnar Arbman, Xiao-Feng Sun

Oncol Rep· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Noxa in colorectal cancer: a study on DNA, mRNA and protein expression.
Agneta K Jansson, Anna M Emterling, Gunnar Arbman, Xiao-Feng Sun

Oncogene· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined deficiency of hMLH1, hMSH2, hMSH3 and hMSH6 is an independent prognostic factor in colorectal cancer.
Agneta Jansson, Gunnar Arbman, Hong Zhang, Xiao-Feng Sun

Int J Oncol· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bax expression decreases significantly from primary tumor to metastasis in colorectal cancer.
Agneta Jansson, Xiao-Feng Sun

J Clin Oncol· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis